OBJECTIVES: This study aimed to conduct a literature review to identify adverse events associated with peripheral vascular access and other commonly used access devices, and assess these events' economic burden and cost implications.

METHODS: A literature review was conducted using PubMed to gather relevant studies and publications reporting on adverse events related to peripheral catheters (PVC), peripherally inserted central catheters (PICC), midline catheters (MC), and central venous catheters (CVC).

RESULTS: The findings revealed varying rates of adverse events across different types of vascular access. The rates of DVT ranged from 2.36% for peripheral catheters (PVC) to 10.91% for central venous catheters (CVC). Bloodstream infections ranged from 0.21% for PVC to 11.82% for CVC. Other adverse events such as pneumothorax, phlebitis, occlusion, and pulmonary embolism also exhibited varying rates across the different access devices. Furthermore, the economic burden associated with these adverse events was calculated by multiplying the rates by their respective costs. The total economic burden was highest for CVC, with a total cost of $3,074.79, followed by PICC ($1,302.07), Midline Catheter (MC) ($1,424.02), and PVC ($328.33).

CONCLUSIONS: The study highlights the prevalence of adverse events associated with different vascular access types, with varying rates observed among these devices.